HLOSF

HEALIOS K K by HEALIOS K K (HLOSF)

About HEALIOS K K by HEALIOS K K (HLOSF)

Healios KK engages in the research, development, and sale of cellular and regenerative medicine. It develops therapies for ischemic stroke, acute respiratory distress syndrome, liver disease, and age-regulated macular degeneration. The company was founded by Tadahisa Kagimoto on February 24, 2011 and is headquartered in Tokyo, Japan.

Details

Daily high
$2.25
Daily low
$2.25
Price at open
$2.25
52 Week High
$2.42
52 Week Low
$0.93
Market cap
202.5M
Dividend yield
0.00%
Volume
288
Avg. volume
141
P/E ratio
-6.08

HEALIOS K K by HEALIOS K K News

Details

Daily high
$2.25
Daily low
$2.25
Price at open
$2.25
52 Week High
$2.42
52 Week Low
$0.93
Market cap
202.5M
Dividend yield
0.00%
Volume
288
Avg. volume
141
P/E ratio
-6.08